Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Cezmi Akdis and Mübeccel Akdis.
Cezmi Akdis
Connection Strength
4.119
Mübeccel Akdis
  1. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021 02; 76(2):428-455.
    View in: PubMed
    Score: 0.229
  2. Advances and recent developments in asthma in 2020. Allergy. 2020 12; 75(12):3124-3146.
    View in: PubMed
    Score: 0.227
  3. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020 10; 75(10):2503-2541.
    View in: PubMed
    Score: 0.223
  4. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020 07; 75(7):1564-1581.
    View in: PubMed
    Score: 0.223
  5. Human type 2 innate lymphoid cells disrupt skin keratinocyte tight junction barrier by IL-13. Allergy. 2019 12; 74(12):2534-2537.
    View in: PubMed
    Score: 0.208
  6. Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid. J Allergy Clin Immunol. 2019 06; 143(6):2190-2201.e9.
    View in: PubMed
    Score: 0.201
  7. Comparison of regulatory B cells in asthma and allergic rhinitis. Allergy. 2019 04; 74(4):815-818.
    View in: PubMed
    Score: 0.200
  8. Laundry detergents and detergent residue after rinsing directly disrupt tight junction barrier integrity in human bronchial epithelial cells. J Allergy Clin Immunol. 2019 05; 143(5):1892-1903.
    View in: PubMed
    Score: 0.199
  9. Chronic rhinosinusitis: pathogenesis, therapy options, and more. Expert Opin Pharmacother. 2018 11; 19(16):1805-1815.
    View in: PubMed
    Score: 0.198
  10. Precision/Personalized Medicine in Allergic Diseases and Asthma. Arch Immunol Ther Exp (Warsz). 2018 Dec; 66(6):431-442.
    View in: PubMed
    Score: 0.197
  11. The concepts of asthma endotypes and phenotypes to guide current and novel treatment strategies. Expert Rev Respir Med. 2018 09; 12(9):733-743.
    View in: PubMed
    Score: 0.195
  12. Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps. J Allergy Clin Immunol. 2018 08; 142(2):665-668.e8.
    View in: PubMed
    Score: 0.189
  13. Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells. J Allergy Clin Immunol. 2018 07; 142(1):178-194.e11.
    View in: PubMed
    Score: 0.184
  14. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol. 2017 Nov; 140(5):1250-1267.
    View in: PubMed
    Score: 0.184
  15. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells. Immunol Rev. 2017 07; 278(1):219-236.
    View in: PubMed
    Score: 0.181
  16. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol. 2018 01; 141(1):300-310.e11.
    View in: PubMed
    Score: 0.178
  17. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016 Feb; 137(2):358-68.
    View in: PubMed
    Score: 0.164
  18. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J Exp Med. 2009 Nov 23; 206(12):2701-15.
    View in: PubMed
    Score: 0.107
  19. Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives. Allergy. 2021 06; 76(6):1640-1660.
    View in: PubMed
    Score: 0.059
  20. ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper. Allergy. 2021 06; 76(6):1624-1628.
    View in: PubMed
    Score: 0.059
  21. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774.
    View in: PubMed
    Score: 0.057
  22. Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020 10; 75(10):2445-2476.
    View in: PubMed
    Score: 0.057
  23. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
    View in: PubMed
    Score: 0.056
  24. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2021 02; 76(2):510-532.
    View in: PubMed
    Score: 0.056
  25. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy. 2021 02; 76(2):533-550.
    View in: PubMed
    Score: 0.056
  26. Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses. J Allergy Clin Immunol. 2019 04; 143(4):1403-1415.
    View in: PubMed
    Score: 0.049
  27. Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis. Clin Transl Allergy. 2018; 8:22.
    View in: PubMed
    Score: 0.048
  28. A Fluorescent Probe to Unravel Functional Features of Cannabinoid Receptor CB1 in Human Blood and Tonsil Immune System Cells. Bioconjug Chem. 2018 02 21; 29(2):382-389.
    View in: PubMed
    Score: 0.047
  29. Exposure to nonmicrobial N-glycolylneuraminic acid protects farmers' children against airway inflammation and colitis. J Allergy Clin Immunol. 2018 01; 141(1):382-390.e7.
    View in: PubMed
    Score: 0.045
  30. The relationship of serum vitamins A, D, E and LL-37 levels with allergic status, tonsillar virus detection and immune response. PLoS One. 2017; 12(2):e0172350.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.